General MedicationsORALGeneric
GANCICLOVIR
GANCICLOVIR
Standard Dose
250MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview GANCICLOVIR is listed in Drugs@FDA under application 076457 (ANDA).
Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength CAPSULE;ORAL - 250MG Sponsor RANBAXY LABS LTD Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview GANCICLOVIR is listed in Drugs@FDA under application 076457 (ANDA). Marketing status: Discontinued Active ingredient GANCICLOVIR Form and strength CAPSULE;ORAL - 250MG Sponsor RANBAXY LABS LTD Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.